“prodisc C Vivo’s unique low-profile design allows for a smaller incision and shorter operative times. The implant’s multiple size options provides a customized fit to the patient’s natural anatomy. The motion preservation technology allows for faster recovery and improved function. I have been impressed with how well my patients have improved after surgery.”– Dr. Theodore Fisher (from the article)
Source: Florida Advanced Spine and Orthopedics
Spine Surgeon Theodore Fisher MD, announced the successful first implantations of the prodisc® C Vivo Cervical Total Disc Replacement (TDR) product. The product was approved in July of 2022 by the U.S. Food and Drug Administration (FDA) for 1-level indications and is part of a portfolio of four FDA approved prodisc C products that allow surgeons to select the implant that best matches a patient’s anatomy and level of disease. Dr. Theodore Fisher MD, is the first spine surgeon in the Tampa area to conduct a total disc replacement procedure using the prodisc C Vivo implant.
The first two prodisc C Vivo procedures were performed at HCA Florida Trinity Hospital and Legacy Surgery Center on a 30 year-old man and 63 year-old man respectively. In each case, the patients were experiencing neck pain along with numbness and tingling down their arms that were not resolved through conservative care methods. Dr. Fisher recognized both as Cervical Total Disc Replacement candidates allowing them to maintain motion in the affected area, as opposed to a Cervical Fusion.
A long-time advocate of the Cervical Disc Replacement procedure for his appropriate patients, the new prodisc C portfolio of FDA approved devices provides Dr. Fisher optionality for his patients. “prodisc C Vivo‘s unique low-profile design allows for a smaller incision and shorter operative times. The implant’s multiple size options provides a customized fit to the patient’s natural anatomy. The motion preservation technology allows for faster recovery and improved function. I have been impressed with how well my patients have improved after surgery.” Said Dr. Fisher.
The prodisc C Vivo system is manufactured by Centinel Spine and has been in clinical use outside the U.S. since 2009 and is currently one of the most frequently implanted TDR devices outside of the U.S. The device has keel-less endplates and combines a unique anatomically-designed superior endplate with lateral spikes to optimize fit and provide immediate fixation. The prodisc C Vivo device incorporates prodisc CORE technology, the basis behind predictable clinical outcomes of the prodisc platform after 30 years and over 225,000 implantations worldwide.
These third party links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Centinel Spine of any of the content, views, or privacy policies of the third party site. Centinel Spine bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Please contact the external site for answers to questions regarding its content.